Skip to main content
Caplight Logo









Renovion, Inc.

Renovion, Inc.

Private
Chapel Hill, North CarolinaHealthcare & Life Scienceshttps://www.renovion.com/

Last Round

VC Round

Apr 3, 2023

Total Funding Raised

$9.15M

Company Overview

Renovion, Inc. is a clinical-stage pharmaceutical company that develops a nebulized therapy to restore mucus clearance and reduce inflammation in the lungs for patients with chronic inflammatory airway diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

nebulized therapychronic lung diseaserespiratory therapyBronchiolitis Obliterans SyndromeBOSorphan drugnon-cystic fibrosis bronchiectasisNCFBElung transplant therapymucus clearanceinhalation therapyclinical stage pharmabiopharmaceutical companychronic bronchitisCOPDFDA Fast Trackcystic fibrosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renovion, Inc. Comparables

Compare Renovion, Inc. with similar companies based on industry and business-model similarity.

Renovion, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aer Therapeutics
86%
Vast Therapeutics
83%
Zambon
78%

Renovion, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 3, 2023
GrantNov 18, 2021
Series AJun 18, 2020
SeedJan 6, 2017

Key People

Founding team and executive leadership

Dan Copeland

CEO

Executive Team

Renovion, Inc. Investors

Notable investors and investment history

Renovion, Inc. investors
InvestorRounds
Onbelay CapitalSeed
KickStart Venture ServicesGrant
First Flight Venture CenterSeed
COPD FoundationVC Round
Leerink PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 48% MoM.

  • Jan 6, 2026

    Monthly visitors grew 100% MoM, reaching 957.

Renovion, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Renovion, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Renovion, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChapel Hill, North Carolina
Employee Range6
Year Founded2013
Last FundingApr 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?